Nuclear Medicine/ Radiopharmaceuticals Market 2020 | Industry Trends, Growth Drivers, Competitive Landscape, Regional Analysis 2026

The MarketWatch News Department was not involved in the creation of this content.

Dec 04, 2020 (The Expresswire) —
The global “Nuclear Medicine/Radiopharmaceuticals Market” size is projected to reach USD 9.67 billion by 2026. According to a report published by Fortune Business Insights, titled “Nuclear Medicine/Radiopharmaceuticals Market Size, Share and Industry Analysis, By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals and Clinics, Diagnostic Centres, and Others) and Regional Forecast, 2019-2026,” the market was valued at USD 4.86 billion in 2018. Driven by increasing number of successful clinical trials, the market will exhibit a CAGR of 9.2% from 2019-2026.

Leading Players operating in the Nuclear Medicine/ Radiopharmaceuticals Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Lantheus Medical Imaging, Inc.
  • Cardinal Health
  • Norgine B.V.
  • Curium
  • Advanced Accelerator Applications (Novartis AG)
  • Bracco Diagnostic Inc.
  • Jubilant Life Sciences Limited
  • Bayer AG
  • Eli Lilly and Company
  • GE Healthcare (General Electric Company)

Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-radiopharmaceuticals-market-101812

Radiopharmaceuticals are substances that are used to diagnose specific medical problems or diseases. Increasing imaging capabilities and efficiencies have led to a wide product adoption across the world. Increasing number of successful clinical trials associated with radiopharmaceuticals will fuel the demand for the product. Recent drug application area discoveries have showcased promise for the companies operating in the market. Technological advancements in nuclear imaging and their applications in diagnosis of cancer and other serious diseases have opened up a huge potential for growth. Growing awareness regarding the adverse effects of chronic diseases, and the need for early diagnosis will aid market growth.

The advancements in imaging systems have played a major role in the growth of the market. Companies are putting in increased efforts towards the manufacturing of diagnostic radiopharmaceuticals. Increasing investments in the research and development (RandD) will create several growth opportunities for market growth. At the same instance, therapeutic radiopharmaceuticals can be used for the treatment of critical illnesses such as cancers.

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nuclear-medicine-radiopharmaceuticals-market-101812

Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Installed Base of PET/PET-CT Scanners For Key Countries, 2015 and 2018
    • Installed Base of Gamma Cameras for Key Countries, 2018
    • PET/PET-CT Procedure Volume for Key Countries, 2018
    • Reimbursement Scenario in Key Countries
    • New Product Launches
    • Key Industry Developments
    • Pipeline Analysis
  • Global Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast By Type
      • Diagnostic Radiopharmaceuticals
        • PET Radiopharmaceuticals
          • FDG-PET/18F
          • 68Ga
          • 68Cu
          • 11C
          • Others
        • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Iodine-123
          • Xenon-133
          • Thallium-201
          • Others
        • Therapeutic Radiopharmaceuticals
      • Market Analysis, Insights and Forecast By Application
        • Neurology
        • Cardiology
        • Oncology
        • Others
      • Market Analysis, Insights and Forecast By End User
        • Hospitals and Clinics
        • Diagnostic Centers
        • Others
      • Market Analysis, Insights and Forecast By Region
        • North
Read more

Digital Medicine Market Size Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 24, 2020 (Market Insight Reports) —
Selbyville, Delaware. Market Study Report LLC: A comprehensive research study on Digital Medicine market added by Market Study Report LLC provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of Digital Medicine market in terms of the demand landscape, driving factors and growth strategies adopted by market players.

This report presents a comprehensive overview, market shares, and growth opportunities of Digital Medicine market by product type, application, key manufacturers and key regions and countries.

Digital medicine technology is an innovative technological technique that has bridged the gap among the healthcare and digital technology. Due to advancement in health care, scientific medicine is pioneered the concept of digital medicine that aims in supporting individualized medicine by recognizing the biology of a patient via a wireless sensor technology and other technologies related to mobile health. Digital medicine is more privileged than recent medical practice as it is more effective, precise, feasible and well distributed technology. Growing healthcare expenditure, high penetration of smartphones, along with high percentage of population with chronic diseases are the few factor responsible for high CAGR of the market over the forecast period.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2495936/?utm_source=Marketwatchtm.com/&utm_medium=AK

Major market player included in this report are:

2Morrow

Ginger

Akili Interactive

Livongo

AliveCor

WellDoc

Mocacare

Proteus Digital Health Voluntis

Omada Health

Digital Medicine Market outlook: Apart from exploring into the various segments, the report clustered on key Digital Medicine Market trends and sectors that are either driving or averting the growth of the Digital Medicine industry. Growth policies and plans are mentioned likewise as producing processes and cost structures also are analyzed. The Digital Medicine Market industry development trends are studied through both secondary and primary sources. Finally, the feasibility of the latest investment comes is assessed and overall analysis conclusions offered in Digital Medicine market analysis report.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Mobile Health

EMR/EHR

Telehealth

Wireless Health

By Application:

Diabetes

Mental Health

Heart Diseases

Others

Research objectives

To study and analyze the global Digital Medicine market size by key regions/countries, type and application, history data from 2016 to 2017, and forecast to 2026.

To understand the

Read more